HIGHLIGHTS
- who: Stefan G. van Ravensteijn et al. from the Department of Medical Oncology, Radboud University Medical Centre, GA Nijmegen, The Netherlands have published the research: Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups, in the Journal: Cancers 2022, 14, 5938. of /2022/
- what: The authors aim to investigate the immune environment in a large group of AS clinical subgroups, to explore those that might benefit from ICI based treatment and combine this with additional genetic data. The aim is to detect differences in the combined immunological and genomic profiles of primary versus . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.